Evidence map›Paper›PMID 41709571›Full record

ArticleEpidemiology and infection2026

Clinical features and trends of severe paediatric group A streptococcal infections in Japan in the post-COVID-19 pandemic era.

Ayumi Tada, Shogo Otake, Taizo Kusano, Tadashi Hoshino, Masayoshi Shinjoh, Taizo Wada, Masaaki Mori, Hiroyuki Moriuchi, Naruhiko Ishiwada, Japanese Severe Paediatric Group A Streptococcal Infections Study Group 8

Abstract readMulticenter Study
In one paragraph

Article in Epidemiology and infection, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ayumi TadaDepartment of Infectious Diseases, Medical Mycology Research Center, Chiba University, Japan.ORCID https://orcid.org/0009-0005-1040-0221
Shogo OtakeDepartment of Pediatrics, Kobe University Graduate School of Medicine School of Medicine, Japan.
Taizo KusanoDivision of Infectious Diseases, Chiba Children's Hospital, Japan.
Tadashi HoshinoDivision of Infectious Diseases, Chiba Children's Hospital, Japan.
Masayoshi ShinjohDepartment of Pediatrics, Keio University School of Medicine, Japan.ORCID https://orcid.org/0000-0002-6291-7186
Taizo WadaDepartment of Pediatrics, Kanazawa University, Japan.
Masaaki MoriDepartment of Lifelong Immunotherapy, Institute of Science, Japan.
Hiroyuki MoriuchiNational Research Center for the Control and Prevention of Infectious Diseases, Nagasaki University, Japan.
Naruhiko IshiwadaDepartment of Infectious Diseases, Medical Mycology Research Center, Chiba University, Japan.ORCID https://orcid.org/0000-0002-7508-1330
Japanese Severe Paediatric Group A Streptococcal Infections Study Group 8

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A global increase in severe group A

Indexed as

COVID-19Streptococcal InfectionsStreptococcus pyogenesAdolescentChildChild, PreschoolFemaleHumansInfantJapanMaleShock, Septicchildrenempyemainvasive group A StreptococcusJapanstreptococcal toxic shock syndrome

Identifiers

PMID41709571
PMCPMC13100923

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.